Index
RUT
Market Cap
6.56B
Enterprise Value
6.59B
Income
275.31M
Sales
1.56B
Book/sh
20.10
Cash/sh
9.09
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
1193
IPO
Jun 25, 2015
P/E
24.28
Forward P/E
15.40
PEG
1.56
P/S
4.22
P/B
5.00
P/C
11.06
P/FCF
16.91
EV/EBITDA
16.85
EV/Sales
4.24
Quick Ratio
2.89
Current Ratio
3.06
Debt/Eq
0.48
LT Debt/Eq
0.48
Option/Short
Yes / Yes
EPS (ttm)
4.14
EPS next Y
6.52
EPS next Q
1.24
EPS this Y
-11.02%
EPS next Y
20.60%
EPS next 5Y
9.88%
EPS past 3/5Y
104.81% -
Sales past 3/5Y
18.13% 35.35%
EPS Y/Y TTM
7.38%
Sales Y/Y TTM
2.35%
EPS Q/Q
-0.79%
Sales Q/Q
2.68%
Insider Own
3.52%
Insider Trans
0.00%
Inst Own
114.36%
Inst Trans
0.28%
ROA
12.15%
ROE
22.21%
ROIC
14.22%
Gross Margin
60.14%
Oper. Margin
19.45%
Profit Margin
17.69%
SMA20
0.37%
SMA50
0.20%
SMA200
9.94%
Trades
Shs Outstand
65.27M
Shs Float
63.00M
52W High
111.86 -10.19%
52W Low
50.15 100.30%
Volatility
0.31% 0.36%
ATR (14)
0.42
RSI (14)
56.05
Beta
0.00
Rel Volume
0.35
Avg Volume
1.38M
Volume
476,348
Perf Week
0.66%
Perf Month
0.81%
Perf Quarter
-0.72%
Perf Half Y
17.50%
Perf YTD
50.95%
Perf Year
81.04%
Perf 3Y
63.14%
Perf 5Y
329.50%
Perf 10Y
1132.64%
Prev Close
100.32
Price
100.46
Change %
0.14%
Analysts 12 incl. previous ratings
Rating Distribution 10 Buy · 2 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 13, 2026 Downgrade M Mizuho
Outperform → Neutral $109 +8.5% Feb 26, 2026 Upgrade W
Mkt Perform → Outperform Dec 12, 2025 Upgrade T Truist
Hold → Buy $80 -20.4% Oct 08, 2025 Downgrade G Goldman
Buy → Neutral $77 -23.4% Aug 12, 2025 Downgrade T Truist
Buy → Hold $63 -37.3% Dec 18, 2024 Initiated G Goldman
Buy $143 +42.3% Sep 03, 2024 Initiated R
Buy $175 +74.2% Jul 10, 2024 Reiterated J
Mkt Outperform $100 → $130 +29.4% Dec 18, 2023 Downgrade W
Outperform → Mkt Perform Dec 04, 2023 Initiated T TD Cowen
Outperform $100 -0.5% Sep 29, 2023 Initiated W
Outperform Mar 08, 2023 Initiated J
Mkt Outperform $120 +19.5% Nov 30, 2022 Initiated S
Outperform Oct 13, 2022 Initiated M Mizuho
Buy $105 +4.5% May 09, 2022 Initiated R B. Riley Securities
Buy $91 -9.4% Apr 13, 2022 Initiated T Truist
Buy $77 -23.4% Feb 01, 2021 Initiated S
Outperform $24 -76.1% Jun 29, 2020 Resumed J Jefferies
Buy $29 -71.1% Aug 16, 2019 Upgrade C
Market Perform → Market Outperform Nov 02, 2017 Upgrade W Wells Fargo
Market Perform → Outperform
Sep-30-26 08:30AM
Sep-29-26 01:52PM
Sep-28-26 08:00AM
Sep-22-26 08:00AM
Sep-11-26 12:28PM
04:56PM
Loading…
Aug-26-26 04:56PM
Aug-14-26 08:00AM
Aug-07-26 02:16PM
Aug-06-26 07:33AM
07:00AM
Aug-03-26 05:26PM
01:41PM
10:58AM
(The Wall Street Journal)
07:31AM
Jul-27-26 06:51PM
08:30AM
Loading…
Jul-23-26 08:30AM
Jun-26-26 04:01PM
Jun-03-26 08:30AM
Jun-02-26 08:00AM
May-27-26 08:30AM
May-22-26 04:36PM
May-21-26 08:30AM
May-19-26 08:30AM
May-07-26 07:26AM
(Associated Press)
+5.63%
07:00AM
Apr-23-26 08:00AM
Mar-17-26 04:01PM
Mar-06-26 04:01PM
Mar-02-26 08:30AM
Feb-26-26 05:03PM
04:15PM
Loading…
04:15PM
07:19AM
07:18AM
(Associated Press Finance)
07:00AM
Feb-24-26 10:08PM
08:30AM
Feb-18-26 04:03AM
Feb-12-26 08:00AM
Jan-03-26 08:10AM
Jan-02-26 08:00AM
Dec-21-25 10:31PM
Dec-17-25 05:11PM
Dec-12-25 12:45PM
Dec-10-25 10:33AM
Nov-24-25 08:30AM
Nov-16-25 11:01PM
Nov-13-25 12:36AM
Nov-11-25 03:56PM
Nov-07-25 12:31AM
Nov-06-25 02:07PM
07:43AM
07:31AM
(Associated Press Finance)
07:02AM
07:00AM
Nov-04-25 10:12PM
09:00AM
Nov-03-25 03:01AM
Oct-30-25 09:49AM
08:30AM
Oct-29-25 08:28AM
Oct-28-25 08:30AM
Oct-23-25 08:30AM
08:30AM
Oct-21-25 03:12PM
Oct-17-25 08:45AM
Oct-13-25 05:03PM
09:28AM
Oct-10-25 09:29AM
Oct-07-25 07:46AM
Sep-30-25 06:06PM
Sep-26-25 09:00AM
Sep-24-25 12:05PM
01:00AM
Sep-23-25 10:10AM
Sep-19-25 06:33PM
Sep-15-25 11:31PM
Sep-09-25 12:02AM
Sep-02-25 08:30AM
04:05AM
Sep-01-25 12:38AM
Aug-29-25 12:26AM
Aug-23-25 03:54AM
Aug-13-25 12:16PM
01:34AM
Aug-12-25 03:45PM
09:40AM
03:13AM
Aug-07-25 12:40PM
Aug-06-25 01:10PM
07:55AM
07:27AM
(Associated Press Finance)
07:00AM
06:45AM
Aug-05-25 09:31AM
Aug-04-25 11:21PM
Jul-28-25 11:11AM
Jul-27-25 10:01AM
Jul-23-25 08:00AM
Jul-22-25 07:00AM
Jul-18-25 12:05AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Blanchfield Paul Former Officer Feb 02 '26 Proposed Sale 66.97 6,713 449,570 Feb 02 01:32 PM Blanchfield Paul Former Officer Jan 06 '26 Proposed Sale 69.53 7,217 501,798 Jan 06 11:43 AM Blanchfield Paul Officer Dec 12 '25 Proposed Sale 66.82 3,265 218,151 Dec 12 03:16 PM Blanchfield Paul Former Officer Nov 26 '25 Proposed Sale 58.31 11,776 686,665 Nov 26 10:43 AM Blanchfield Paul Former Officer Nov 14 '25 Proposed Sale 52.70 16,530 871,106 Nov 14 02:13 PM
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
CEO & Executive Chairperson Ms. Mary Anne Heino
CFA Mr. Robert J. Marshall Jr.
Chief Administrative Officer Mr. Daniel M. Niedzwiecki
Chief Commercial Officer Ms. Amanda M. Morgan
Head of Research & Development Dr. Ludger Dinkelborg Ph.D.
L